These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27587472)

  • 21. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
    Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
    PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.
    Regieli JJ; Jukema JW; Grobbee DE; Kastelein JJ; Kuivenhoven JA; Zwinderman AH; van der Graaf Y; Bots ML; Doevendans PA
    Eur Heart J; 2008 Nov; 29(22):2792-9. PubMed ID: 18957472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis.
    Guo SX; Yao MH; Ding YS; Zhang JY; Yan YZ; Liu JM; Zhang M; Rui DS; Niu Q; He J; Guo H; Ma RL
    Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27608031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol-Associated Mechanisms in Etiology of Age-Related Macular Degeneration.
    Burgess S; Davey Smith G
    Ophthalmology; 2017 Aug; 124(8):1165-1174. PubMed ID: 28456421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.
    Chasman DI; Paré G; Zee RY; Parker AN; Cook NR; Buring JE; Kwiatkowski DJ; Rose LM; Smith JD; Williams PT; Rieder MJ; Rotter JI; Nickerson DA; Krauss RM; Miletich JP; Ridker PM
    Circ Cardiovasc Genet; 2008 Oct; 1(1):21-30. PubMed ID: 19802338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature.
    Yu M; Liang C; Kong Q; Wang Y; Li M
    Lipids Health Dis; 2020 Jan; 19(1):1. PubMed ID: 31900179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome].
    Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):553-8. PubMed ID: 24078569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association of lipid-lowering response to statins in combined study populations.
    Barber MJ; Mangravite LM; Hyde CL; Chasman DI; Smith JD; McCarty CA; Li X; Wilke RA; Rieder MJ; Williams PT; Ridker PM; Chatterjee A; Rotter JI; Nickerson DA; Stephens M; Krauss RM
    PLoS One; 2010 Mar; 5(3):e9763. PubMed ID: 20339536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of GWAS-based candidate genes with HDL-cholesterol levels before and after bariatric surgery in the Swedish obese subjects study.
    Sarzynski MA; Jacobson P; Rankinen T; Carlsson B; Sjöström L; Carlsson LM; Bouchard C
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E953-7. PubMed ID: 21430028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesteryl ester transfer protein rs1532624 gene polymorphism is associated with reduced response to statin therapy.
    Yehya A; Irshaid Y; Saleh AA
    Curr Mol Pharmacol; 2013 Nov; 6(3):156-62. PubMed ID: 24160573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.
    Jafri H; Alsheikh-Ali AA; Karas RH
    Ann Intern Med; 2010 Dec; 153(12):800-8. PubMed ID: 21173414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
    Nurmohamed NS; Ditmarsch M; Kastelein JJP
    Cardiovasc Res; 2022 Nov; 118(14):2919-2931. PubMed ID: 34849601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the
    Yu C; Bakshi A; Watts GF; Renton AE; Fulton-Howard B; Goate AM; Natarajan P; Chasman DI; Robman L; Woods RL; Guymer R; Wolfe R; Thao LTP; McNeil JJ; Tonkin AM; Nicholls SJ; Lacaze P
    J Am Heart Assoc; 2023 Nov; 12(21):e031459. PubMed ID: 37929782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
    Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ
    J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.
    Chu AY; Giulianini F; Barratt BJ; Ding B; Nyberg F; Mora S; Ridker PM; Chasman DI
    Circ Cardiovasc Genet; 2015 Oct; 8(5):688-95. PubMed ID: 26273092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia.
    Bercovich D; Friedlander Y; Korem S; Houminer A; Hoffman A; Kleinberg L; Shochat C; Leitersdorf E; Meiner V
    Atherosclerosis; 2006 Mar; 185(1):97-107. PubMed ID: 16002074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.